Form 4: HCA Healthcare Director Nancy Ann DeParle Acquires Shares Through Equity Award

Director Nancy Ann DeParle acquired 610 shares of HCA Healthcare common stock through an annual director equity award.

Summary

• On April 29, 2024, Nancy Ann DeParle, a director of HCA Healthcare, Inc., acquired 610 shares of common stock.
• The acquisition was part of an annual director equity award.
• The shares were acquired at a price of $0.00.
• Following the transaction, DeParle directly owns 20,756 shares of HCA Healthcare common stock.
• The restricted share units will vest on the earlier of the company's 2025 annual shareholders' meeting or the first anniversary of the grant date.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally viewed as a positive sign, indicating confidence in the company's performance. However, it's a routine transaction related to director compensation.

Positives

• The acquisition of shares by a director signals confidence in the company's future.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of restricted share units in 2025 suggests a continued relationship between the director and the company.

Industry Context

Director share acquisitions are common in the healthcare industry and are often seen as a positive sign of alignment between management and shareholder interests.

Comparison to Industry Standards

• Comparing director equity awards at HCA Healthcare to those at similar companies like Universal Health Services (UHS) or Tenet Healthcare (THC) would provide context on the size and structure of the award.
• Benchmarking the vesting schedule against industry norms for director compensation packages would also be relevant.

Key Dates